277 related articles for article (PubMed ID: 25218600)
1. Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up.
Olivan-Blázquez B; Herrera-Mercadal P; Puebla-Guedea M; Pérez-Yus MC; Andrés E; Fayed N; López-Del-Hoyo Y; Magallon R; Roca M; Garcia-Campayo J
Pain; 2014 Dec; 155(12):2517-2525. PubMed ID: 25218600
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up.
Olivan-Blázquez B; Puebla M; Masluk B; Pérez-Yus MC; Arcega R; Andrés E; López-del-Hoyo Y; Magallon R; Roca M; Garcia-Campayo J
Trials; 2013 Jan; 14():3. PubMed ID: 23286311
[TBL] [Abstract][Full Text] [Related]
3. Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up.
Fayed N; Olivan-Blázquez B; Herrera-Mercadal P; Puebla-Guedea M; Pérez-Yus MC; Andrés E; López del Hoyo Y; Magallon R; Viguera L; Garcia-Campayo J
CNS Neurosci Ther; 2014 Nov; 20(11):999-1007. PubMed ID: 25230216
[TBL] [Abstract][Full Text] [Related]
4. Changes in metabolites in the brain of patients with fibromyalgia after treatment with an NMDA receptor antagonist.
Fayed N; Oliván B; Lopez Del Hoyo Y; Andrés E; Perez-Yus MC; Fayed A; Angel LF; Serrano-Blanco A; Roca M; Garcia Campayo J
Neuroradiol J; 2019 Dec; 32(6):408-419. PubMed ID: 31215319
[TBL] [Abstract][Full Text] [Related]
5. Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.
Kulkarni J; Thomas N; Hudaib AR; Gavrilidis E; Grigg J; Tan R; Cheng J; Arnold A; Gurvich C
CNS Drugs; 2018 Feb; 32(2):179-187. PubMed ID: 29549516
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Peyro Saint Paul L; Creveuil C; Heinzlef O; De Seze J; Vermersch P; Castelnovo G; Cabre P; Debouverie M; Brochet B; Dupuy B; Lebiez P; Sartori É; Clavelou P; Brassat D; Lebrun-Frenay C; Daplaud D; Pelletier J; Coman I; Hautecoeur P; Tourbah A; Defer G
J Neurol Sci; 2016 Apr; 363():69-76. PubMed ID: 27000224
[TBL] [Abstract][Full Text] [Related]
7. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
[TBL] [Abstract][Full Text] [Related]
8. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial.
Boxer AL; Knopman DS; Kaufer DI; Grossman M; Onyike C; Graf-Radford N; Mendez M; Kerwin D; Lerner A; Wu CK; Koestler M; Shapira J; Sullivan K; Klepac K; Lipowski K; Ullah J; Fields S; Kramer JH; Merrilees J; Neuhaus J; Mesulam MM; Miller BL
Lancet Neurol; 2013 Feb; 12(2):149-56. PubMed ID: 23290598
[TBL] [Abstract][Full Text] [Related]
9. Correlational analysis and predictive validity of psychological constructs related with pain in fibromyalgia.
Maurel S; Rodero B; Lopez-del-Hoyo Y; Luciano JV; Andrés E; Roca M; Bergos Rdel M; Ruiz-Lancina Y; García-Campayo J
BMC Musculoskelet Disord; 2011 Jan; 12():4. PubMed ID: 21214948
[TBL] [Abstract][Full Text] [Related]
10. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
[TBL] [Abstract][Full Text] [Related]
11. Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study.
Noruzzadeh R; Modabbernia A; Aghamollaii V; Ghaffarpour M; Harirchian MH; Salahi S; Nikbakht N; Noruzi N; Tafakhori A
Headache; 2016 Jan; 56(1):95-103. PubMed ID: 26638119
[TBL] [Abstract][Full Text] [Related]
12. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain--results of a randomized double-blinded, placebo-controlled trial.
Maier C; Dertwinkel R; Mansourian N; Hosbach I; Schwenkreis P; Senne I; Skipka G; Zenz M; Tegenthoff M
Pain; 2003 Jun; 103(3):277-283. PubMed ID: 12791434
[TBL] [Abstract][Full Text] [Related]
14. Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.
Bakchine S; Loft H
J Alzheimers Dis; 2007 Jul; 11(4):471-9. PubMed ID: 17656827
[TBL] [Abstract][Full Text] [Related]
15. Effect of Memantine on Cognitive Performance in Patients Under Electroconvulsive Therapy: A Double-Blind Randomized Clinical Trial.
Alizadeh NS; Maroufi A; Jamshidi M; Hassanzadeh K; Gharibi F; Ghaderi E
Clin Neuropharmacol; 2015; 38(6):236-40. PubMed ID: 26536019
[TBL] [Abstract][Full Text] [Related]
16. Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial.
Schulz JB; Rainer M; Klünemann HH; Kurz A; Wolf S; Sternberg K; Tennigkeit F
J Alzheimers Dis; 2011; 25(3):463-75. PubMed ID: 21471647
[TBL] [Abstract][Full Text] [Related]
17. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW;
Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548
[TBL] [Abstract][Full Text] [Related]
18. Memantine for dementia.
Areosa Sastre A; McShane R; Sherriff F
Cochrane Database Syst Rev; 2004 Oct; (4):CD003154. PubMed ID: 15495043
[TBL] [Abstract][Full Text] [Related]
19. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
[TBL] [Abstract][Full Text] [Related]
20. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
Brown PD; Pugh S; Laack NN; Wefel JS; Khuntia D; Meyers C; Choucair A; Fox S; Suh JH; Roberge D; Kavadi V; Bentzen SM; Mehta MP; Watkins-Bruner D;
Neuro Oncol; 2013 Oct; 15(10):1429-37. PubMed ID: 23956241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
